Skip to Content


In the US, Mobic (meloxicam systemic) is a member of the drug class Nonsteroidal anti-inflammatory drugs and is used to treat Juvenile Rheumatoid Arthritis, Osteoarthritis and Rheumatoid Arthritis.

US matches:

Ingredient matches for Mobic


Meloxicam is reported as an ingredient of Mobic in the following countries:

  • Argentina
  • Australia
  • Belgium
  • China
  • Colombia
  • Ecuador
  • Finland
  • France
  • Hong Kong
  • Ireland
  • Italy
  • Japan
  • Lebanon
  • Malaysia
  • Malta
  • New Zealand
  • Oman
  • Peru
  • Philippines
  • South Africa
  • South Korea
  • Taiwan
  • Thailand
  • Tunisia
  • United States
  • Vietnam

Meloxicam meglumin (a derivative of Meloxicam) is reported as an ingredient of Mobic in the following countries:

  • Belgium

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.